"The “negative voices” concentrating on the flaws in the FDA’s approval as “not pro-patient.”"

[Farooqji]

Before its Aduhelm decision, we believe the FDA’s worst approval in recent memory belonged to Exondys 51, a drug to treat Duchenne muscular dystrophy. Patient advocacy organizations (PAOs) vociferously supported its approval at a heated FDA advisory committee meeting.

statnews.com/2021/07/23/pat...

[park_bear]

Nuplazid another contender: healthunlocked.com/cure-par...

[chartist in reply to park_bear]

I missed this one.This is what can happen when there is such huge amounts of money at play. Based on your linked to post, the drug sounds expensive and ineffective and possibly dangerous.

Art